[go: up one dir, main page]

EA200801507A1 - Оптически активные карбаматы, способ их получения и их применение в качестве фармацевтических промежуточных соединений - Google Patents

Оптически активные карбаматы, способ их получения и их применение в качестве фармацевтических промежуточных соединений

Info

Publication number
EA200801507A1
EA200801507A1 EA200801507A EA200801507A EA200801507A1 EA 200801507 A1 EA200801507 A1 EA 200801507A1 EA 200801507 A EA200801507 A EA 200801507A EA 200801507 A EA200801507 A EA 200801507A EA 200801507 A1 EA200801507 A1 EA 200801507A1
Authority
EA
Eurasian Patent Office
Prior art keywords
production
application
optically active
intermediate compounds
pharmaceutical intermediate
Prior art date
Application number
EA200801507A
Other languages
English (en)
Other versions
EA015801B1 (ru
Inventor
Тибор Мезеи
Эникё Мольнар
Петер Тринка
Ференц Барта
Зольтан Катона
Донат Дьёрди Верецкеине
Кальман Надь
Ласло Понго
Дьюла Лукач
Марта Порч-Маккаи
Жужанна Эвингер
Дьюла Симиг
Original Assignee
Эгиш Дьёдьсердьяр Ньильваношан Мюкёдё Ресвеньтаршашаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьёдьсердьяр Ньильваношан Мюкёдё Ресвеньтаршашаг filed Critical Эгиш Дьёдьсердьяр Ньильваношан Мюкёдё Ресвеньтаршашаг
Publication of EA200801507A1 publication Critical patent/EA200801507A1/ru
Publication of EA015801B1 publication Critical patent/EA015801B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к 1-[(4-хлорфенил)фенилметил]-4-(2,2,2-трихлорэтоксикарбонил)пиперазину формулы (IV) и его оптическим изомерам, способам их получения и применению соединения формулы (IV) при получении 1-(4-хлорфенил)фенилметилпиперазина и его оптических изомеров и солей. 1-(4-Хлорфенил)фенилметилпиперазин и его оптические изомеры представляют собой важные промежуточные соединения при получении неседативных активных фармацевтических ингредиентов антигистаминового типа.
EA200801507A 2005-12-08 2006-12-08 Оптически активные карбаматы, способ их получения и их применение в качестве фармацевтических промежуточных соединений EA015801B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0501139A HU227074B1 (en) 2005-12-08 2005-12-08 An optically active carbamic acid derivative, method for producing the same and use as a pharmaceutical intermediate
PCT/HU2006/000109 WO2007066163A2 (en) 2005-12-08 2006-12-08 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates

Publications (2)

Publication Number Publication Date
EA200801507A1 true EA200801507A1 (ru) 2008-10-30
EA015801B1 EA015801B1 (ru) 2011-12-30

Family

ID=89986439

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801507A EA015801B1 (ru) 2005-12-08 2006-12-08 Оптически активные карбаматы, способ их получения и их применение в качестве фармацевтических промежуточных соединений

Country Status (10)

Country Link
US (1) US7851627B2 (ru)
EP (1) EP1963296B1 (ru)
JP (1) JP2009518379A (ru)
CN (1) CN101356162A (ru)
AT (1) ATE545638T1 (ru)
EA (1) EA015801B1 (ru)
HU (1) HU227074B1 (ru)
NO (1) NO20083068L (ru)
UA (1) UA92195C2 (ru)
WO (1) WO2007066163A2 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100928776B1 (ko) * 2007-09-07 2009-11-25 한미약품 주식회사 (r)-1-[(4-클로로페닐)페닐메틸]피페라진 또는 이의 염의제조방법
KR101427100B1 (ko) 2007-10-23 2014-08-08 주식회사 씨트리 광학활성을 갖는 1-[(4-클로로페닐)페닐메틸]-피페라진의제조방법
EP2062881B1 (en) * 2007-11-21 2011-02-23 Synthon B.V. Process for making N-(diphenylmethyl)piperazines
US7989623B2 (en) * 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
WO2009147389A2 (en) * 2008-06-02 2009-12-10 Cipla Limited Processes for the synthesis of levocetirizine and intermediates for use therein
WO2010057515A1 (en) * 2008-11-21 2010-05-27 Synthon B.V. Levocetirizine by menthyl intermediate
US20100145049A1 (en) * 2008-11-21 2010-06-10 Jie Zhu Process for making n-(diphenylmethyl)piperazines
WO2012101475A1 (en) 2011-01-27 2012-08-02 Jubilant Life Sciences Limited An improved process for the preparation of antihistaminic drugs via a novel carbamate intermediate
US8580886B2 (en) 2011-09-20 2013-11-12 Dow Corning Corporation Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates
US9518072B2 (en) 2011-12-02 2016-12-13 Dow Corning Corporation Ester-functional silanes and the preparation and use thereof; and use of iminium compounds as phase transfer catalysts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE508650A (ru)
US2709169A (en) * 1955-05-24 X c chs
BE501277A (fr) 1951-02-15 1952-05-09 H Morren Procede de preparation de 1,4-aralcoyl-piperazines.
IT1140978B (it) * 1980-05-23 1986-10-10 Selvi & C Spa 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
JP2002249487A (ja) * 2001-02-22 2002-09-06 Sumitomo Chem Co Ltd 4−(tert−ブトキシカルボニル)ピペラジン誘導体、その光学活性な酸付加塩、それらの製造法、およびそれらを用いる光学活性な1−[(置換フェニル)フェニルメチル]ピペラジンの製造法。

Also Published As

Publication number Publication date
US20090221823A1 (en) 2009-09-03
US7851627B2 (en) 2010-12-14
HUP0501139A2 (en) 2007-08-28
EP1963296A2 (en) 2008-09-03
NO20083068L (no) 2008-07-08
ATE545638T1 (de) 2012-03-15
JP2009518379A (ja) 2009-05-07
CN101356162A (zh) 2009-01-28
EA015801B1 (ru) 2011-12-30
HU227074B1 (en) 2010-06-28
HU0501139D0 (en) 2006-02-28
EP1963296B1 (en) 2012-02-15
WO2007066163A2 (en) 2007-06-14
WO2007066163A3 (en) 2007-08-02
UA92195C2 (ru) 2010-10-11

Similar Documents

Publication Publication Date Title
NO20083068L (no) Optisk aktive karbamater, fremgangsmate for deres fremstilling og anvendelse derav som farmasoytiske mellomprodukter
NO20091892L (no) Krystallinsk form av (3S)-3-(N-(N`-(2-tert-butylfenyl)oksamyl) alaninyl)amino-5-(2`,3`,5`,6`-tetrafluorfenoksy)-4 oksopentanoisk syre
EA201070698A1 (ru) Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
CY1112916T1 (el) 3-ζ-1-(4-(ν-((4-μεθυλ-πιπεραζιν-1-υλ)-μεθυλκαρβονυλ)-ν-μεθυλ-αμινο)-ανιλινο)-1-φαινυλ-μεθυλενο-6-μεθοξυκαρβονυλ-2-ινδολινονη-μονοαιθανοσουλφονικη και η χρηση αυτης ως φαρμακευτικη συνθεση
EA200901514A1 (ru) Новая сольватная и кристаллическая форма производных карбамоилциклогексана
NO20063501L (no) Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese
NO20070445L (no) Pyrimidinderivater.
AR051965A1 (es) Sales de la n-[2-( { (3r)-1-[trans-4-hidroxi-4-(6- metoxipiridin-3-il)-ciclohexil] pirrolidin-3- il} amino)-2- oxoetil]-3-(trifluormetil) benzamida
MX2010003849A (es) Antagonistas de cgrp.
NO20074303L (no) 7-{4-[2-(2,6-diklor-4-metylfenoksy)etoksy]fenyl}-3,9-diazabisyklo-[3.3.1]non-6-en-6-karboksylsyresyklopropyl-(2,3-dimetylbenzyl)amid som renininhibitor til behandling av hypertensjon
MEP41408A (en) Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
DE602005002475D1 (de) Verfahren zur vorbereitung von telithromycin
NO20092005L (no) MTP-Inhiberende piperidin- eller piperazinsubstituerte tetrahydro-naftalen-1-karboksylsyreforbindelser
NO20075385L (no) 7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner
UY29369A1 (es) Nueva sal de 1-(-3-(3-(4-clorofenil) propoxi(propil) -piperidina
PE20090839A1 (es) Derivados de isoxazol-imidazol
NO20085052L (no) 4-((fluorofenoksyl)fenylmetyl)piperidin metansulfonat: anvendelser, synteseprosess og farmasoytiske sammensetninger
NO20084674L (no) 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser
NO20076000L (no) Aminosyrederivater
NO20075080L (no) Pyridylmetylsulfonderivater
EA201170736A1 (ru) Синтез и новые солевые формы (r)-3-((e)-2-(пирролидин-3-ил)винил)-5-(тетрагидропиран-4-илокси) пиридина
EA200801797A2 (ru) Способ получения эсциталопрама
NO20073058L (no) Novel diazabicyclononene derivative
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
PE20070180A1 (es) Compuestos de bencilpiperazina como agonistas del receptor gpr38

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU